Niche DRAM Upcycle May Extend to 2028; OW
The market assumes the DRAM cycle will normalize by 2026, but structural shortages in niche DRAM are extending the upcycle to 2028, creating a divergence from…
Topics
Research linked to EV demand, batteries, autos, charging, supply chains and electrification.
The market assumes the DRAM cycle will normalize by 2026, but structural shortages in niche DRAM are extending the upcycle to 2028, creating a divergence from…
The market prices J.B. Hunt as a cyclical freight recovery play, but a structural margin expansion is underway, driven by regulatory capacity removal and…
The market misprices Info Edge's recruitment acceleration as a cyclical recovery, but the data reveals a structural ARPU inflection driven by AI-Rex…
The market prices Larsen & Toubro as a cyclical EPC play exposed to GCC capex slowdown, but the reality is that Saudi's resilience-led capex wave is…
The market still prices Datadog as a single observability vendor, but the company is rapidly evolving into a multi-platform AI and security provider. DASH…
The market treats BlueScope as a single cyclical steel company, but the structural divergence between US and Asian steel spreads is creating a regional…
The market assumes The Lottery Corporation Limited (TLC.AX) can sustain stable earnings and dividend growth, but structural lottery turnover declines and…
The market continues to price Continental as a diversified industrial conglomerate, but the imminent ContiTech sale will fundamentally alter its valuation…
The market interprets BCG's FY27 growth guide as a structural slowdown, but B2C advertiser data across Real Estate, Auto, and Jobs/Services remains resilient…
The market treats Novartis (NOVN.S) as a stable growth story with a supportive pipeline, but the reality is that its current valuation already prices in full…
The market treats Cochlear's growth as decelerating toward low single digits, but actual implant volumes grew 8.8% YoY in FY24A, and the upcoming UK NHS…
The market treats Orange as a uniformly declining telecom, but the data reveals a structural divergence between accelerating Spain revenue and contracting…
The market assumes softer sales growth implies proportional earnings weakness for LPP SA, but the reality is that margin expansion is offsetting revenue cuts…
The market treats Fresenius Medical Care as a broad-based recovery story, but the data reveals EBIT growth is driven by cost cuts rather than revenue…
APAC Specialist Sales JPMORGAN KR Auto Parts/Robotics; Initiate Mobis (N)/Mando (UW), Autoever (U/G to N), CH Auto; Policy from EU/CH, China’s HDT…
Overview of stock investment thesis 7 Debate 1: Given Luckin’s 30k ML China store count, what factors support further store expansion? 8 Store upside…
(Ymn) GSE GSE GSE GSE GSE GSE GSE CoE FY3/26 FY3/27 FY3/28 FY3/29 FY3/27 FY Q1 Q2 Q3 Q4 FY FY FY FY Sales 1,583,719 391,700 406,900 453,300 464,300 1,716,200…
Resmed (RMD.AX) Income Statement Growth Rates (pcp) CAGR June Year End (US$m) FY22A FY23A FY24A FY25A FY26E FY27E FY28E FY22A FY23A FY24A FY25A FY26E FY27E…